SYRESpyre Therapeutics, Inc.

$93.63

$93.63

$14.8252 weeks$108.94

Is it growing?

Is SYRE growing?

Years of annual history on file: 12
Years of annual history on file · FY2014 to FY2025, as filed

Details›

Revenue FY2021: $19M
Revenue FY2022: $2.3M
Revenue FY2023: $886K
Revenue FY2024: $0
Revenue FY2025: $0

Annual income statements as filed with the SEC.

Biotechnology

Ranks #7 of 145 by Smart Score

Immunovant, Inc.

Protagonist Therapeutics, Inc.

Rhythm Pharmaceuticals, Inc.

ABIVAX Société Anonyme

ImmunityBio, Inc.